Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hartmann

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 2010
[Lupus-nephritis--diagnosis and treatment]Gudrun E Norby, Karoline Lerang, Hallvard Holdaas, et al.
BMC Nephrology|October 21, 2016
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipientsJulia Smedbråten, Geir Mjøen, Anders Hartmann, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 19, 2016
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant RecipientsHanne Skou Jørgensen, Ivar Anders Eide, Anders Hartmann, et al.
Transplantation|September 29, 2017
The Authors' ReplyErlend Johannessen Egeland, Elisabet Størset, Ida Robertsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 4, 2006
[Staging and measurement of renal function in chronic renal conditions]Anders Hartmann, Hallvard Holdaas, Ingrid Os, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipientsSolbjørg Sagedal, Knut P Nordal, Anders Hartmann, et al.
Transplantation|July 25, 2006
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipientsAnders Asberg, Karsten Midtvedt, Pål D Line, et al.
Journal of the American Society of Nephrology : JASN|May 12, 2006
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patientsJøran Hjelmesaeth, Thor Ueland, Allan Flyvbjerg, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Plos Pathogens|May 11, 2017
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infectionJessica Rose, Vincent C Emery, Deepali Kumar, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 2010
[Lupus-nephritis--diagnosis and treatment]Gudrun E Norby, Karoline Lerang, Hallvard Holdaas, et al.
BMC Nephrology|October 21, 2016
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipientsJulia Smedbråten, Geir Mjøen, Anders Hartmann, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 19, 2016
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant RecipientsHanne Skou Jørgensen, Ivar Anders Eide, Anders Hartmann, et al.
Transplantation|September 29, 2017
The Authors' ReplyErlend Johannessen Egeland, Elisabet Størset, Ida Robertsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 4, 2006
[Staging and measurement of renal function in chronic renal conditions]Anders Hartmann, Hallvard Holdaas, Ingrid Os, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipientsSolbjørg Sagedal, Knut P Nordal, Anders Hartmann, et al.
Transplantation|July 25, 2006
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipientsAnders Asberg, Karsten Midtvedt, Pål D Line, et al.
Journal of the American Society of Nephrology : JASN|May 12, 2006
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patientsJøran Hjelmesaeth, Thor Ueland, Allan Flyvbjerg, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Pageof 20